Vedolizumab in Mild to Moderate Crohn's Disease Patients Naive to Biological Therapy: a Multicentric Observational Study

被引：0
|
作者：
Dotti, A. Z. [1 ]
Vilela, E. G. [2 ]
Chebli, J. M. F.
Chebli, L. A. [3 ]
Magro, D. O. [3 ,4 ]
Steinwurz, F. [5 ]
Argollo, M. [6 ]
Carvalho, N. S. [6 ]
Parente, J. M. L. [7 ]
Parra, R. S. [8 ]
Perin, R. L. [9 ]
Flores, C. [10 ]
Morsoletto, E. M. [11 ]
Ferreira, S. D. C. [12 ]
Ludvig, J. C. [13 ]
Kaiser, R. L., Jr. [14 ]
Queiroz, N. S. F. [15 ]
Faria, M. A. G.
Nicollelli, G. M. [16 ]
Andrade, A. R. [17 ]
Kotze, P. G. [18 ]
机构：
[1] Univ Fed Parana, Gastroenterol, Curitiba, Parana, Brazil
[2] Univ Fed Minas Gerais UFMG, Gastroenterol, Belo Horizonte, MG, Brazil
[3] Univ Fed Juiz Fora, Gastroewnterol, Juiz De Fora, Brazil
[4] Univ Campinas UNICAMP, Colorectal Surg, Campinas, Brazil
[5] Hosp Israelita Albert Einstein, Gastroenterol, Sao Paulo, Brazil
[6] Sao Luiz Hosp, Gastroenterol, Sao Paulo, Brazil
[7] Univ Fed Piaui, Gastroenterol, Teresina, Brazil
[8] Univ Sao Paulo, Colorectal Surg, Ribeirao Preto, Brazil
[9] Univ Passo Fundo, Colorectal Surg, Passo Fundo, RS, Brazil
[10] Inst Aparelho Digestivo, Gastroenterol, Porto Alegre, RS, Brazil
[11] Hosp Sao Vicente, Gastroenterol, Curitiba, Parana, Brazil
[12] Univ Sao Paulo, Gastroenterol, Ribeirao Preto, Brazil
[13] Clin ESADI, Gastroenterol, Blumenau, Brazil
[14] Kaiser Clin, Colorectal Surg, Sao Jose Do Rio Preto, Brazil
[15] Hosp Santa Cruz, Santa Cruz, CA, Brazil
[16] Kaiser Clin, Colorectal Surg, Sao Jose Do Rio Preto, Brazil
[17] Univ Estadual, Gastroenterol, Salvador, Brazil
[18] Pontificia Univ Catolica Parana PUCPR, IBD outpatient Clin, Curitiba, Brazil
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P586
引用
收藏
页码：714 / 715
页数：2
相关论文
共 50 条
  • [31] Pulmonary Histoplasmosis During Vedolizumab Therapy For Crohn's Disease
    Zahiruddin, F.
    Nan, X.
    Zimmerman, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] A retrospective cohort study on vedolizumab trough levels in Crohn's disease patients
    Pokryszka, J.
    Stadlmann, M.
    Primas, C.
    Gerold, N.
    Reinisch, S.
    Novacek, G.
    Reinisch, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 919 - 919
  • [33] Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients
    Chapuis-Biron, Constance
    Bourrier, Anne
    Nachury, Maria
    Nancey, Stephane
    Bouhnik, Yoram
    Serrero, Melanie
    Armengol-Debeir, Laura
    Buisson, Anthony
    Tran-Minh, My-Linh
    Zallot, Camille
    Fumery, Mathurin
    Bouguen, Guillaume
    Abitbol, Vered
    Viennot, Stephanie
    Chanteloup, Elise
    Rajca, Sylvie
    Dib, Nina
    Parmentier, Anne-Laure
    Peyrin-Biroulet, Laurent
    Vuitton, Lucine
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (07) : 719 - 727
  • [34] Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational Study
    Kotze, Paulo Gustavo
    Spinelli, Antonino
    da Silva, Rodolff Nunes
    de Barcelos, Ivan Folchini
    Teixeira, Fybio Vieira
    Saad-Hossne, Rogerio
    de Albuquerque, Idblan Carvalho
    Olandoski, Marcia
    Kotze, Lorete Maria da Silva
    Suzuki, Yasuo
    Yamada, Akihiro
    Takeuchi, Ken
    Sacchi, Matteo
    Yamamoto, Takayuki
    [J]. INTESTINAL RESEARCH, 2015, 13 (03) : 259 - 265
  • [35] Effectiveness and safety of ustekinumab in bio-naive Crohn's disease patients: a multicentre observational retrospective study
    Delgado Teresa, Valdes
    Martin Raul, Olmedo
    Marisa, Iborra
    de Guise Claudia, Herrera
    Esteban, Fuentes-Valenzuela
    Luigi, Melcarne
    Ma Mar, Martin-Rodriguez
    Casso Lilyan, Kolle
    Parga Luisa, De Castro
    Diaz Angel, Ponferrada
    Lidon Raquel, Vicente
    Marcos Noemi, Mancenido
    Jimenez Benito, Velayos
    Saez Marta, Lazaro
    Cauce Beatriz, Lopez
    Gismero Francisco, Mesonero
    Pau, Gilabert Alvarez
    Federico, Arguelles-Arias
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [36] Biological therapy in Crohn's disease
    Gordon, JN
    MacDonald, TT
    [J]. HOSPITAL MEDICINE, 2003, 64 (12): : 708 - 712
  • [37] Safety of dual biological therapy in Crohn's disease: a case series of vedolizumab in combination with other biologics
    Mao, Eric J.
    Lewin, Sara
    Terdiman, Jonathan P.
    Beck, Kendall
    [J]. BMJ OPEN GASTROENTEROLOGY, 2018, 5 (01):
  • [38] REMISSION TO VEDOLIZUMAB IS NOT HIGHER IN TNF-NAIVE COMPARED TO TNF-PRETREATED PATIENTS WITH CROHN'S DISEASE
    Mader, Orla
    Michetti, Pierre F.
    Biedermann, Luc
    Hruz, Petr
    Juillerat, Pascal
    Pittet, Valerie
    Rogler, Gerhard
    Seibold, Frank
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S645 - S645
  • [39] Characteristics of biological therapy in pediatric patients with Crohn's disease
    Tarnok, Andras
    Kiss, Zoltan
    Kadenczki, Orsolya
    Veres, Gabor
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (03) : 181 - 196
  • [40] Higher vedolizumab levels are associated with deep remission in patients with Crohn's disease and ulcerative colitis on maintenance therapy with vedolizumab
    Yarur, A.
    Bruss, A.
    Jain, A.
    Kondragunta, V.
    Hester, K.
    Luna, T.
    Agrawal, D.
    Patel, A.
    Fox, C.
    Werner, S.
    Naik, S.
    Stein, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S38 - S38
12345